Skip to main content
SpringerLink
Log in

Membrane-bound/soluble IL-2 receptor (IL-2R) and levels of IL-1α, IL-2, and IL-6 in the serum and in the PBMC culture supernatants from 17 patients with hematological malignancies

  • Published:
Cell Biophysics Aims and scope Submit manuscript

Abstract

The present study investigated the peripheral blood mononuclear cells (PBMC) blastic responses to PHA, PHA plus recombinant IL-2 (rIL-2) and rIL-2 alone; the expression of membrane-bound IL-2R on PHA-stimulated PBMC; and the levels of IL-1α, IL-2, IL-6, and sIL-2R in serum and in culture supernatants from PHA-stimulated PBMC in 17 patients with hematological malignancies (mean age 58.5 yr, range 22–82): 6 with non-Hodgkin’s lymphoma (NHL), 4 with Hodgkin’s lymphoma (HL), 5 with Hairy cell leukemia, 1 with chronic myelogenous leukemia, and 1 with chronic lymphocytic leukemia. The patients with HL and NHL with active disease (AD) were separated from those in clinical remission. The patients with AD were studied at diagnosis (obviously before therapy) and the patients in clinical remission were out of therapy since at least 6 mo. The lymphocyte blastogenic response to PHA was significantly lower in patients with HL and NHL with AD than in the control group. The response to rIL-2 alone was in the same range in the control group and in HL and NHL AD patients. By adding rIL-2 to PHA there was an increase of the blastogenic response of the same patients. The percentage of CD25 expressed on PHA-stimulated lymphocytes from patients with HL and NHL AD and from normal subjects is in the same range. Serum levels of IL-2, IL-6, and sIL-2R were significantly higher in HL and NHL AD patients than in controls as well as in all other hematological malignancies. Supernatants derived from PHA-stimulated PBMC were assessed for the presence of cytokines and sIL-2R by ELISA. The levels of IL-2, IL-6, and sIL-2R were significantly lower in HL and NHL AD patients than in controls as well as in all other hematological malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ricevuti, G., Mazzone, A., Pasotti, D., and Notario, A. (1992) The cytokine network: their role in physiopathology and therapeutic implications.Int. J. Immunopathol. Pharmacol. 5, 67–76.

    Google Scholar 

  2. Dinarello, C. A. (1988) Biology of interleukin-1.FASEB J. 2, 108–112.

    PubMed  CAS  Google Scholar 

  3. Kampschmidt, R. F. (1984) Infection, inflammation and interleukin-1.Lymphokine Res. 2, 97–110.

    Google Scholar 

  4. Diamanstein, T. (1990) Interleukin-2 and the interleukin-2 receptor complex, inBiology and Clinical Application of IL 2 (Rees, R. C., ed.), Oxford Academic Press, Oxford, UK, pp. 15–22.

    Google Scholar 

  5. Semenzato, G., Pizzolo, G., and Zambello, R. (1992) The interleukin-2/interleukin-2 receptor system: structural, immunological, and clinical features.Int. J. Clin. Lab. Res. 22, 133–142.

    Article  PubMed  CAS  Google Scholar 

  6. Rubin, L. A., Jay, G., and Nelson, D. L. (1986) The released interleukin 2 receptor binds interleukin 2 efficiently.J. Immunol. 137, 3841–3844.

    PubMed  CAS  Google Scholar 

  7. Dukovich, M., Wano, Y., Bich-Thuy, L. T., Katz, P., Cullen, B. R., Kehrl, J. H., and Greene, W. C. (1987) A second human interleukin-2 binding protein that may be a component of hihg-affinity interleukin-2 receptor.Nature (Lond.) 327, 518–522.

    Article  CAS  Google Scholar 

  8. Robb, R. J. and Greene, W. C. (1987) Internalization of interleukin-2 is mediated by the beta-chain of the high-affinity interleukin-2 receptor.J. Exp. Med. 165, 1201–1206.

    Article  PubMed  CAS  Google Scholar 

  9. Robb, R. J., Rusk, C. M., Yodoi, J., and Greene, W. C. (1987) Interleukin-2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors.Proc. Natl. Acad. Sci. USA 84, 2002–2006.

    Article  PubMed  CAS  Google Scholar 

  10. Sharon, M., Klausner, R. D., Cullen, B. R., Chizzonite, R., and Leonard, W. (1987) Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions.Science (Wash.) 234, 859–863.

    Article  Google Scholar 

  11. Siegel, J. P., Sharon, M., Smith, P. L., and Leonard, W. J. (1987) The IL-2 receptor beta-chain of the high-affinity interleukin-2 receptor.Science (Wash.) 238, 75–78.

    Article  CAS  Google Scholar 

  12. Smith, K. A. (1987) The two-chain structure of high-affinity IL-2 receptors.Immunol. Today 8, 11–13.

    Article  CAS  Google Scholar 

  13. Tsudo, M., Goldman, C. K., Bongiovanni, K. F., Chan, W. C., Winton, E. F., Yagita, M., et al. (1987) The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin-2 activation of these cells.Proc. Natl. Acad. Sci. USA 84, 5394–5398.

    Article  PubMed  CAS  Google Scholar 

  14. Tsudo, M., Kozak, R. W., Goldman, C. K., and Waldmann, T. A., (1986) Demonstration of a non-Tac peptide that binds interleukin-2 receptor complex.Proc. Natl. Acad. Sci. USA 83, 9694–9698.

    Article  PubMed  CAS  Google Scholar 

  15. Wang, H. M. and Smith, K. A. (1987) The interleukin-2 receptor: functional consequences of its bimolecular structure.J. Exp. Med. 166, 1055–1069.

    Article  PubMed  CAS  Google Scholar 

  16. Robb, R. J., Munck, A., and Smith, K. A. (1983) T-cell growth factor receptors: quantitation, specificity, and biological relevance.J. Exp. Med. 154, 1455–1474.

    Article  Google Scholar 

  17. Robb, R. J., Greene, W. C., and Rusk, C. M. (1984) Low-and high-affinity cellular receptors for interleukin 2: implications for the level of Tac antigen.J. Exp. Med. 160, 1126–1146.

    Article  PubMed  CAS  Google Scholar 

  18. Korsmeyer, S. J., Greene, W. C., Cossman, J., Hsu, S. M., Jensen, J. P., Neckers, L. M., et al. (1983) Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.Proc. Natl. Acad. Sci. USA 80, 4522–4526.

    Article  PubMed  CAS  Google Scholar 

  19. Jung, L. K. L., Hara, T., and Fu, S. M. (1984) Detection and functional studies of p60-65 (Tac antigen) on activated human B cells.J. Exp. Med. 160, 1597–1602.

    Article  PubMed  CAS  Google Scholar 

  20. Tsudo, M., Uchiyama, T., and Uchino, H. (1984) Expression of Tac antigen on activated normal human B cells.J. Exp. Med. 160, 612–617.

    Article  PubMed  CAS  Google Scholar 

  21. Waldmann, T. A., Goldman, C. K., Robb, R. J., Depper, J. M., Leonard, W. J., Sharrow, S. O., et al. (1984) Expression of interleukin-2 receptors on activated human B cells.J. Exp. Med. 160, 1450–1466.

    Article  PubMed  CAS  Google Scholar 

  22. Pizzolo, G., Chilosi, M., Vinante, F., Dazzi, F., Lestani, M., Perona, G., et al. (1987) Soluble Interleukin-2 receptors in the serum of patients with Hodgkin’s disease.Br. J. Cancer 55, 427, 428.

    PubMed  CAS  Google Scholar 

  23. Fox, D. A., Hussey, R. E., Fitzgerald, K. A., Bensussan, A., Daley, J. F., Schlossman, S. F., et al. (1985) Activation of human thymocytes via the 50 kD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3− populations.J. Immunol. 134, 330–335.

    PubMed  CAS  Google Scholar 

  24. Herrmann, F., Cannistra, S. A., Levine, H., and Griffin, J. D. (1985) Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells.J. Exp. Med. 162, 1111–1116.

    Article  PubMed  CAS  Google Scholar 

  25. Uchiyama, T. (1988) Abnormal interleukin 2 receptor expression in adult T cells leukemia, inInterleukin 2 (Smith, K. A., ed.), Academic, San Diego, CA, pp. 1–35.

    Google Scholar 

  26. Foa, R., Giovarelli, M., Jemma, C., Fierro, M. T., Lusso, P., Ferrando, M. L., et al. (1985) Interleukin-2 (IL-2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL-2 is absorbed the neoplastic B cell population.Blood 66, 614–619.

    PubMed  CAS  Google Scholar 

  27. Lantz, O., Grillot-Courvalin, C., Schmitt, C., Fermand, J. P., and Brouet, J. C. (1985) Interleukin 2-induced proliferation of leukemic human B cells.J. Exp. Med. 161, 1225–1330.

    Article  PubMed  CAS  Google Scholar 

  28. Pizzolo, G., Chilosi, M., and Semenzato, G. (1987) The soluble inter-leukin-2 receptor in haematological disorders.Br. J. Haematol. 67, 377–380.

    PubMed  CAS  Google Scholar 

  29. Tsang, K. Y., Fudenberg, H. H., Galbraith, G. M. P., Donnelly, R. P., Bishop, L. R., and Koopman, W. R. (1985) Partial restoration of impaired interleukin-2 production and Tac antigen (putative interleukin-2 receptor) expression in patients with acquired immune deficiency syndrome by isoprinosine treatment in vitro.J. Clin. Invest. 75, 1538–1544.

    Article  PubMed  CAS  Google Scholar 

  30. Malkowsky, M., Jira, M., Gao, L., Loveland, B., Malkovska, V., Dalgleish, A. G., and Webster, A. D. (1986) Reduced expression of interleukin-2 receptors in hypogammaglobulinaemia: a possible cause of higher cancer incidence.Lancet i, 1442, 1443.

    Article  Google Scholar 

  31. Rubin, L. A., Kurman, C. C., Fritz, M. E., Biddison, W. E., Boutin, B., Yarchoan, R., et al. (1985) Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro.J. Immunol. 135, 3172–3177.

    PubMed  CAS  Google Scholar 

  32. Greene, W. C., Leonard, W. J., Depper, J. M., Nelson, D. L., and Waldmann, T. A. (1986) The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses.Ann. Int. Med. 105, 560–572.

    PubMed  CAS  Google Scholar 

  33. Voss, S. D., Hank, J. A., Nobis, C. A., Fisch, P., Sosman, J. A., and Sondel, P. M. (1989) Serum levels of the low-affinity interleukin-2 receptor molecule (TAC) during IL-2 therapy reflect systemic lymphoid mass activation.Cancer Immunol. Immunother. 29, 261–269.

    Article  PubMed  CAS  Google Scholar 

  34. Chilosi, M., Pizzolo, G., Semenzato, G., and Cetto, G. L. (1986) Detection of a soluble form of the receptor for interleukin-2 in the serum of patients with hairy cell leukaemia.Int. J. Biol. Markers 1, 101–104.

    PubMed  CAS  Google Scholar 

  35. Pizzolo, G., Chilosi, M., Ambrosetti, A., Agostini, C., Masciarelli, M., Trentin, L., et al. (1986) Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of alpha-interferon therapy on clinical parameters and on natural killer in vitro activity.Blood 68(Suppl. 1), 228a.

    Google Scholar 

  36. Semenzato, G., Foa, R., Agostini, C., Zambello, R., Trentin, L., Vinante, F., et al. (1987) High serum levels of soluble interleukin-2 receptor (s IL-2 R) in patients with B chronic lymphocytic leukemia (B-CLL).Blood 70, 396–400.

    PubMed  CAS  Google Scholar 

  37. Mantovani, G., Coiana, A., Cossu, F., Floris, C., Proto, E., Macciò, A., et al. (1986) Peripheral blood lymphocyte response to exogenous interleukin 2 by PHA-prestimulated and non-PHA-prestimulated cells in patients with cancer.Tumori 72, 375–382.

    PubMed  CAS  Google Scholar 

  38. Mantovani, G., Coiana, A., Massidda, A., Proto, E., Floris, C., Macciò, A., et al. (1987) Interleukin 2 (IL-2) relationships with the cancer-related immunodeficiency: in vitro response to exogenous IL-2 by PHA-activated and non PHA-activated peripheral blood mononuclear cells from cancer patients.Diagn. Clin. Immunol. 5, 104–111.

    PubMed  CAS  Google Scholar 

  39. Mantovani, G., Coiana, A., Massidda, A., Proto, E., Floris, C., Macciò, A., et al. (1988) Role of interleukin 2 (IL-2) in cancer-related immune deficiency: in vitro response to IL-2, production of IL-2 and IL-2 receptor expression in patients with advanced cancer.Cancer Detec. Prev. 12, 149–159.

    PubMed  CAS  Google Scholar 

  40. Zembala, M., Mytar, B., Popiela, T., and Asherson, G. L. (1977) Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients.Int. J. Cancer 19, 605–613.

    Article  PubMed  CAS  Google Scholar 

  41. Mantovani, G., Macciò, A., Astara, G., Contini, L., Esu, S., Littera, S. et al. (1993) Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies.Cell Biophys. 22, 79–99.

    PubMed  CAS  Google Scholar 

  42. Bauer, J. and Herrman, F. (1991) Interleukin-6 in clinical medicine.Ann. Hematol. 62, 203–210.

    Article  PubMed  CAS  Google Scholar 

  43. Moradi, M. M., Carson, L. F., Weinberg, B., Haney, A. F., Twiggs, L. B., and Ramakrishnan, S. (1993) Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer.Cancer 72, 2433–2440.

    Article  PubMed  CAS  Google Scholar 

  44. Scambia, G., Testa, U., Benedetti Panici, P., Martucci, R., Foti, E., Petrini, M., et al. (1993) IL-6 serum levels in patients with gynecological tumors.Proc. Annu. Meet. Am. Assoc. Cancer Res. 34, A577.

    Google Scholar 

  45. Ballester, O., Corrado, C., Moscinski, L., Bruno, S., and Burgess, J. (1992) Clinical significance of serum interleukin-6 (IL-6) levels in patients with multiple myeloma (MM).Proc. Annu. Meet. Am. Soc. Clin. Oncol. 11, A217.

    Google Scholar 

  46. Gelin, J., Moldawer, L. L., Lonnroth, C., Sherry, B., Chizzonite, R., and Lundholm, K. (1991) Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia.Cancer Res. 51, 415–421.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, University of Cagliari, 09124, Cagliari, Italy

    Giovanni Mantovani, Antonio Maccio, Paola Lai, Massimo Ghiani, Emiliano Turnu & G. Sergio Del Giacco

Authors
  1. Giovanni Mantovani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonio Maccio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paola Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Massimo Ghiani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Emiliano Turnu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Sergio Del Giacco
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mantovani, G., Maccio, A., Lai, P. et al. Membrane-bound/soluble IL-2 receptor (IL-2R) and levels of IL-1α, IL-2, and IL-6 in the serum and in the PBMC culture supernatants from 17 patients with hematological malignancies. Cell Biophysics 27, 1–14 (1995). https://doi.org/10.1007/BF02822523

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02822523

Index Entries

Search

Navigation